Literature DB >> 26308883

Shared Predisposition in the Association Between Cannabis Use and Subcortical Brain Structure.

David Pagliaccio1, Deanna M Barch2, Ryan Bogdan3, Phillip K Wood4, Michael T Lynskey5, Andrew C Heath6, Arpana Agrawal6.   

Abstract

IMPORTANCE: Prior neuroimaging studies have suggested that alterations in brain structure may be a consequence of cannabis use. Siblings discordant for cannabis use offer an opportunity to use cross-sectional data to disentangle such causal hypotheses from shared effects of genetics and familial environment on brain structure and cannabis use.
OBJECTIVES: To determine whether cannabis use is associated with differences in brain structure in a large sample of twins/siblings and to examine sibling pairs discordant for cannabis use to separate potential causal and predispositional factors linking lifetime cannabis exposure to volumetric alterations. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional diagnostic interview, behavioral, and neuroimaging data were collected from community sampling and established family registries from August 2012 to September 2014. This study included data from 483 participants (22-35 years old) enrolled in the ongoing Human Connectome Project, with 262 participants reporting cannabis exposure (ie, ever used cannabis in their lifetime). MAIN OUTCOMES AND MEASURES: Cannabis exposure was measured with the Semi-Structured Assessment for the Genetics of Alcoholism. Whole-brain, hippocampus, amygdala, ventral striatum, and orbitofrontal cortex volumes were related to lifetime cannabis use (ever used, age at onset, and frequency of use) using linear regressions. Genetic (ρg) and environmental (ρe) correlations between cannabis use and brain volumes were estimated. Linear mixed models were used to examine volume differences in sex-matched concordant unexposed (n = 71 pairs), exposed (n = 81 pairs), or exposure discordant (n = 89 pairs) sibling pairs.
RESULTS: Among 483 study participants, cannabis exposure was related to smaller left amygdala (approximately 2.3%; P = .007) and right ventral striatum (approximately 3.5%; P < .005) volumes. These volumetric differences were within the range of normal variation. The association between left amygdala volume and cannabis use was largely owing to shared genetic factors (ρg = -0.43; P = .004), while the origin of the association with right ventral striatum volumes was unclear. Importantly, brain volumes did not differ between sex-matched siblings discordant for use (fixed effect = -7.43; t = -0.93, P = .35). Both the exposed and unexposed siblings in pairs discordant for cannabis exposure showed reduced amygdala volumes relative to members of concordant unexposed pairs (fixed effect = 12.56; t = 2.97; P = .003). CONCLUSIONS AND RELEVANCE: In this study, differences in amygdala volume in cannabis users were attributable to common predispositional factors, genetic or environmental in origin, with little support for causal influences. Causal influences, in isolation or in conjunction with predispositional factors, may exist for other brain regions (eg, ventral striatum) or at more severe levels of cannabis involvement and deserve further study.

Entities:  

Mesh:

Year:  2015        PMID: 26308883      PMCID: PMC4624286          DOI: 10.1001/jamapsychiatry.2015.1054

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  34 in total

Review 1.  Biometrical genetics.

Authors:  David M Evans; N A Gillespie; N G Martin
Journal:  Biol Psychol       Date:  2002-10       Impact factor: 3.251

2.  Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users.

Authors:  Joseph P Schacht; Kent E Hutchison; Francesca M Filbey
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

3.  IV. NIH Toolbox Cognition Battery (CB): measuring language (vocabulary comprehension and reading decoding).

Authors:  Richard C Gershon; Jerry Slotkin; Jennifer J Manly; David L Blitz; Jennifer L Beaumont; Deborah Schnipke; Kathleen Wallner-Allen; Roberta Michnick Golinkoff; Jean Berko Gleason; Kathy Hirsh-Pasek; Marilyn Jager Adams; Sandra Weintraub
Journal:  Monogr Soc Res Child Dev       Date:  2013-08

Review 4.  Is cannabis neurotoxic for the healthy brain? A meta-analytical review of structural brain alterations in non-psychotic users.

Authors:  Matteo Rocchetti; Alessandra Crescini; Stefan Borgwardt; Edgardo Caverzasi; Pierluigi Politi; Zerrin Atakan; Paolo Fusar-Poli
Journal:  Psychiatry Clin Neurosci       Date:  2013-09-30       Impact factor: 5.188

Review 5.  Neurotoxicology of cannabis and THC: a review of chronic exposure studies in animals.

Authors:  A C Scallet
Journal:  Pharmacol Biochem Behav       Date:  1991-11       Impact factor: 3.533

6.  Cannabis legalization and public health: legal niceties, commercialization and countercultures.

Authors:  Robin Room
Journal:  Addiction       Date:  2014-03       Impact factor: 6.526

7.  A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA.

Authors:  K K Bucholz; R Cadoret; C R Cloninger; S H Dinwiddie; V M Hesselbrock; J I Nurnberger; T Reich; I Schmidt; M A Schuckit
Journal:  J Stud Alcohol       Date:  1994-03

8.  Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates.

Authors:  Tiziana Rubino; Daniela Vigano'; Natalia Realini; Cinzia Guidali; Daniela Braida; Valeria Capurro; Chiara Castiglioni; Francesca Cherubino; Patrizia Romualdi; Sanzio Candeletti; Mariaelvina Sala; Daniela Parolaro
Journal:  Neuropsychopharmacology       Date:  2008-01-02       Impact factor: 7.853

9.  Quantitative changes in hippocampal structure following long-term exposure to delta 9-tetrahydrocannabinol: possible mediation by glucocorticoid systems.

Authors:  P W Landfield; L B Cadwallader; S Vinsant
Journal:  Brain Res       Date:  1988-03-08       Impact factor: 3.252

10.  The minimal preprocessing pipelines for the Human Connectome Project.

Authors:  Matthew F Glasser; Stamatios N Sotiropoulos; J Anthony Wilson; Timothy S Coalson; Bruce Fischl; Jesper L Andersson; Junqian Xu; Saad Jbabdi; Matthew Webster; Jonathan R Polimeni; David C Van Essen; Mark Jenkinson
Journal:  Neuroimage       Date:  2013-05-11       Impact factor: 6.556

View more
  37 in total

Review 1.  Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.

Authors:  Alison C Burggren; Anaheed Shirazi; Nathaniel Ginder; Edythe D London
Journal:  Am J Drug Alcohol Abuse       Date:  2019-07-31       Impact factor: 3.829

2.  Cannabis and alcohol use, affect and impulsivity in psychiatric out-patients' daily lives.

Authors:  Timothy J Trull; Andrea M Wycoff; Sean P Lane; Ryan W Carpenter; Whitney C Brown
Journal:  Addiction       Date:  2016-07-24       Impact factor: 6.526

3.  Legalizing marijuana.

Authors:  Marco Leyton
Journal:  J Psychiatry Neurosci       Date:  2016-03       Impact factor: 6.186

Review 4.  Resting-State Functional Connectivity in the Human Connectome Project: Current Status and Relevance to Understanding Psychopathology.

Authors:  Deanna M Barch
Journal:  Harv Rev Psychiatry       Date:  2017 Sep/Oct       Impact factor: 3.732

5.  Brain Volume Abnormalities in Youth at High Risk for Depression: Adolescent Brain and Cognitive Development Study.

Authors:  David Pagliaccio; Kira L Alqueza; Rachel Marsh; Randy P Auerbach
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-10-18       Impact factor: 8.829

6.  Anterior cingulate volume reductions in abstinent adolescent and young adult cannabis users: Association with affective processing deficits.

Authors:  Kristin E Maple; Alicia M Thomas; Megan M Kangiser; Krista M Lisdahl
Journal:  Psychiatry Res Neuroimaging       Date:  2019-04-30       Impact factor: 2.376

7.  Urinary tetrahydrocannabinol is associated with poorer working memory performance and alterations in associated brain activity.

Authors:  Max M Owens; Shannon McNally; Tashia Petker; Michael T Amlung; Iris M Balodis; Lawrence H Sweet; James MacKillop
Journal:  Neuropsychopharmacology       Date:  2018-10-10       Impact factor: 7.853

8.  Lifetime use of cannabis from longitudinal assessments, cannabinoid receptor (CNR1) variation, and reduced volume of the right anterior cingulate.

Authors:  Shirley Y Hill; Vinod Sharma; Bobby L Jones
Journal:  Psychiatry Res Neuroimaging       Date:  2016-07-19       Impact factor: 2.376

9.  Resting-state functional connectivity of the human habenula in healthy individuals: Associations with subclinical depression.

Authors:  Benjamin A Ely; Junqian Xu; Wayne K Goodman; Kyle A Lapidus; Vilma Gabbay; Emily R Stern
Journal:  Hum Brain Mapp       Date:  2016-03-16       Impact factor: 5.038

10.  Subcortical Local Functional Hyperconnectivity in Cannabis Dependence.

Authors:  Peter Manza; Dardo Tomasi; Nora D Volkow
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.